The new injectable facility of Eugia Steriles Private Limited (a 100% subsidiary of Eugia Pharma Specialities Limited and a stepdown subsidiary of the company), situated at Parawada Mandal, Anakapalli District, Andhra Pradesh, has recently started the commercial operations.

The United States Food and Drug Administration (US FDA) inspected the above-mentioned facility from March 28, 2024 to April 05, 2024. The inspection closed with 3 observations. The observations are procedural in nature and will be responded to within the stipulated time.